Wipada Samprasit

Dr. Wipada Samprasit

Rangsit University, Pathum Thani, Thailand
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Wipada SamprasitWipada Samprasit
Wipada Samprasit
PAPrasert Akkaramongkolporn
Prasert Akkaramongkolporn
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
TRTheerasak Rojanarata
Theerasak Rojanarata
RKRuchadaporn Kaomongkolgit
Ruchadaporn Kaomongkolgit
POPraneet Opanasopit
Praneet Opanasopit

1 March 2015 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Wipada SamprasitWipada Samprasit
Wipada Samprasit
RKRuchadaporn Kaomongkolgit
Ruchadaporn Kaomongkolgit
MSMonrudee Sukma
Monrudee Sukma
TRTheerasak Rojanarata
Theerasak Rojanarata
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
POPraneet Opanasopit
Praneet Opanasopit

17 January 2021 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
Wipada SamprasitWipada Samprasit
Wipada Samprasit
POPraneet Opanasopit
Praneet Opanasopit
BCBenchawan Chamsai
Benchawan Chamsai
α-Mangostin-loaded mucoadhesive nanoparticles (NPs) were prepared for colon-targeted drug delivery against colorectal cancer cells using pH-dependent composite mucoadhesive NPs. Chitosan (CS) and thiolated chitosan (TCS) were used to form the NPs, following by genipin (GP) crosslinking and the surface modification by Eudragit® L100 (L100). The particle size, morphologies and characteristics of NPs were observed. The α-mangostin loading and release patterns were investigated. In vitro mucoadhesive properties were examined by the wash-off method. In addition, the anti-tumour activity was tested on colorectal cancer cells. The results showed that NPs were slightly oblong in shape with particle size ranging between 300 and 900 nm. The small size of NPs was found with TCS and larger NPs were observed by GP and L100 process. However, GP and L100 provided an increase in α-mangostin loading, limited the release of α-mangostin in the upper gastrointestinal tract, and enhanced α-mangostin delivery to the colon. The TCS-based NPs with GP and L100 exhibited strong mucoadhesion to colon mucosa, more than uncoated-NPs and CS-based NPs. Moreover, NPs exhibited the anti-tumour activity. Therefore, the mucoadhesive TCS-based NPs could be a promising candidate for a controlled-release drug delivery system of α-mangostin to the colon. Graphical Abstract

26 February 2015 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
Wipada SamprasitWipada Samprasit
Wipada Samprasit
TRTheerasak Rojanarata
Theerasak Rojanarata
PAPrasert Akkaramongkolporn
Prasert Akkaramongkolporn
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
RKRuchadaporn Kaomongkolgit
Ruchadaporn Kaomongkolgit
POPraneet Opanasopit
Praneet Opanasopit

7 December 2017 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
Wipada SamprasitWipada Samprasit
Wipada Samprasit
PAPrasert Akkaramongkolporn
Prasert Akkaramongkolporn
RKRuchadaporn Kaomongkolgit
Ruchadaporn Kaomongkolgit
POPraneet Opanasopit
Praneet Opanasopit
This work deals with fast-dissolving drug delivery systems of meloxicam (MX) derived from electrospun polyvinylpyrrolidone (PVP)/2-hydroxypropyl-β-cyclodextrin (HPβCD) nanofiber mats. Electrospinning of solutions with different solvent systems [dimethylformamide (DMF) and ethyl alcohol (EtOH)] was performed. Prepared films were evaluated for morphology, physical, and mechanical properties. MX content, dissolving time, MX release, and cytotoxicity of films were investigated. In vivo studies were also performed in healthy human volunteers. The results showed that MX/HPβCD complexes improved the solubility of MX. PVP also increased MX solubility and the stability of MX/HPβCD complexes. Films were successfully prepared by two solvent systems with fiber in the nanometer range. MX was well incorporated into the films (100% efficiency). The X-ray patterns and DSC experiment indicated an amorphous form of MX. A fast disintegration time and burst release of MX was obtained from EtOH system. Cytotoxicity testing of the films produced by EtOH system proved safer than the DMF system. In vivo studies revealed that films rapidly dissolved in the mouth and had a less bitter taste than MX. These results suggest that electospun films from EtOH system may be a good candidate for fast-dissolving drug delivery systems to increase palatability of dosage forms.

15 July 2015 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
MCMichael T. Cook
Michael T. Cook
SSS. A. Schmidt
S. A. Schmidt
ELE. Lee
E. Lee
Wipada SamprasitWipada Samprasit
Wipada Samprasit
POP. Opanasopit
P. Opanasopit
Vitaliy KhutoryanskiyVitaliy Khutoryanskiy
Vitaliy Khutoryanskiy
Thiol-bearing microgels have been synthesised from copolymerisation of 2-(acetylthio)ethylacrylate and 2-hydroxyethylmethacrylate, and subsequent deprotection using sodium thiomethoxide. The concentration of thiol groups on these microgels could be tailored by use of different molar ratios of the two monomers. These thiol-bearing microgels were shown to adhere to ex vivo porcine urinary bladder, which was correlated with their level of thiolation. By simply mixing solutions of thiol-bearing microgels and doxorubicin, high levels of drug loading into the microgels could be achieved. Thiol-bearing microgels controlled the release of doxorubicin in a time-dependent manner over several hours. These doxorubicin-loaded thiol-bearing microgels could have application in the treatment of early-stage bladder cancers. The method used represents a new ‘bottom-up’ approach for the synthesis of novel mucoadhesive microgels.